Chen Zeqing, Huang Shijie, Liu Muqing
Institute of Future Lighting, Academy for Engineering and Technology, Fudan University, Shanghai, China.
Zhongshan Fudan Joint Innovation Center, Zhongshan City, China.
Photodermatol Photoimmunol Photomed. 2022 Jan;38(1):3-11. doi: 10.1111/phpp.12715. Epub 2021 Jul 7.
Photobiomodulation (PBM) uses low-intensity visible or near-infrared light to produce beneficial effects on cells or tissues, such as brain therapy, wound healing. Still there is no consistent recommendation on the parameters (dose, light mode, wavelength, irradiance) and protocols (repetition, treatment duration) for its clinical application. Herein, we summarize the current PBM parameters for the treatment of melanoma, and we also discuss the potential photoreceptors and downstream signaling mechanisms in the PBM treatment of melanoma cells. It is hypothesized that PBM may inhibit the melanoma cells by activating mitochondria, OPNs, and other receptors. Regardless of the underlying mechanisms, PBM has been shown to be beneficial in treating melanoma. Through further in-depth studies of the underlying potential mechanisms, it can strengthen the applications of PBM for the therapy of melanoma.
光生物调节作用(PBM)使用低强度可见光或近红外光对细胞或组织产生有益影响,如脑部治疗、伤口愈合。然而,对于其临床应用的参数(剂量、光照模式、波长、辐照度)和方案(重复次数、治疗持续时间)仍没有一致的建议。在此,我们总结了目前用于治疗黑色素瘤的PBM参数,并且还讨论了PBM治疗黑色素瘤细胞时潜在的光感受器和下游信号传导机制。据推测,PBM可能通过激活线粒体、骨桥蛋白(OPNs)和其他受体来抑制黑色素瘤细胞。无论潜在机制如何,PBM已被证明在治疗黑色素瘤方面是有益的。通过对潜在机制的进一步深入研究,可以加强PBM在黑色素瘤治疗中的应用。